[1]
Muzafarova Sh.Sh and Shagazatova B.Kh, “FEATURES OF THE IMPACT OF NOVEL GLUCOSE-LOWERING DRUG CLASSES ON CARDIOVASCULAR OUTCOMES IN PATIENTS WITH TYPE 2 DIABETES MELLITUS”, Eth Int Multi Res Conf, vol. 3, no. 2, pp. 20–21, May 2026.